Categories
Health

CVS stops giving J&J Covid vaccines in pharmacies, nonetheless provides pictures at some MinuteClinics

A nurse will give a syringe to the FEMA-sponsored COVID-19 vaccination site at Valencia State College on the first day the site resumes offering the Johnson & Johnson vaccine.

Paul Hennessy | LightRakete | Getty Images

CVS Health has discontinued Johnson & Johnson’s single-dose Covid-19 vaccine in its pharmacies and only makes vaccinations available in about 10% of its retail locations, the company told CNBC on Wednesday.

The drugstore chain said it made the change in the past few weeks. Customers can still get the syringes at nearly 1,000 MinuteClinic locations in 25 states, and Washington DC MinuteClinics are located in some of the company’s drug stores and provide medical care and other services such as diagnostic tests and vaccines.

CVS pharmacies will continue to offer the two-dose vaccines Pfizer-BioNTech and Moderna Covid nationwide, according to CVS spokesman Mike DeAngelis. He declined to say how many pharmacies were affected by the change, however said it would help with vaccine supply to the drugstore chain.

CVS has more than 9,900 retail locations according to its 2020 annual report.

J&J did not immediately respond to CNBC’s request to comment on the change.

J & J’s vaccine was touted as a blessing by federal health officials when it was approved by the FDA in late February because it only requires one dose and can be stored at refrigerator temperatures for months. Since then, it has suffered from poor public perception of its overall effectiveness, concerns about rare side effects, and production delays.

For some Americans, concerns about the one-shot vaccine have increased with the advent of the Delta variant, which can spread more easily and cause more serious illness than the original coronavirus. Some people have even gone so far as to look for an extra dose not yet recommended by the Centers for Disease Control and Prevention. This week, San Francisco health officials announced they would allow patients who received a J&J vaccine to have a second vaccination from Pfizer-BioNTech or Moderna.

The change by CVS will affect the availability of the recordings for many Americans. J & J’s vaccine is already not getting as much uptake in the US as mRNA vaccines.

According to the CDC, approximately 13.5 million doses of the J&J vaccine had been administered in the US by Tuesday. This compares to a combined total of 333.6 million doses for the vaccine from Pfizer and Moderna.

Dr. Paul Offit, who served on advisory boards for both the CDC and the Food and Drug Administration, said J & J’s vaccine really “suffered” after federal health officials urged states in April to suspend vaccination “as a precaution.” “While examining six women who developed a rare but severe bleeding disorder, said

The recommended break was lifted 10 days later after U.S. officials determined that the benefits of the vaccinations outweigh their risks.

“I think the public is hearing that the vaccine is going off the market for a while and it’s just hard to get past that scarlet letter,” said Offit, also director of the Vaccine Education Center at Children’s Hospital of Philadelphia.

The company and U.S. health officials have claimed the single-use vaccine is safe and highly effective, particularly against serious illness, hospitalizations, and death. J&J reported last month that new research found that its vaccine was effective against the highly contagious Delta even eight months after being vaccinated.

– CNBC’s Nate Rattner contributed to this report.

Categories
Business

Elon Musk and Memes: A Controversy Over Giving Creators Credit score

Elon Musk – the Tesla CEO, SpaceX founder and soon-to-be Saturday Night Live host – is an open admirer of memes.

“Whoever controls the memes controls the universe,” tweeted Mr. Musk last summer. He has called the visual jokes “modern art” and shares them regularly on Twitter, where he has more than 52 million followers.

Mr. Musk doesn’t make a lot of memes himself. Instead, he finds them online and has others send them their favorites. Sometimes he republishes his favorites without naming their origins.

This practice is not uncommon. Lots of people on the internet share other people’s memes without giving credit to the creators, in part because it can be difficult to spot credit. Memes are based on reinterpretations of joke formats, and it’s not always clear where they start.

But the fact that Elon Musk frequently steals memes has essentially become a meme in itself. And it’s not always felt to be very funny.

For comedians and content creators, memes are valuable intellectual property. Nick Noerdlinger, 23, executive director of the Meme Insider website, noted that granting or denying credit has business implications. “Because the internet is so big and wide, the only thing that draws people back to someone who can ultimately make a living on the platform is credit,” he said. “In the creative economy, even without credit, the creators would not be able to make money, build a brand around them, and appeal to an audience.

In the past few years, viral meme accounts that have seen great success and monetization by republishing other developers’ work without credit or payment have met with backlash. In 2019, a conversation about this issue was sparked by a campaign against an Instagram account operated by Jerry Media. It helped change the standards that brands and top influencers adhere to today.

Quinn Heraty, a lawyer specializing in intellectual property law, found that rapper Ludacris was sued by the LittleThings website in 2017 for posting an illustration from the website on his Instagram without acknowledging it. (The parties have reached an agreement.)

Ms. Heraty said that without “transformative use” there could be a case for copyright infringement. “If he brushes the picture off the picture and publishes it without reference to the original creator, it shows willpower,” she said of Mr. Musk.

Generally, when a brand uses a meme for marketing purposes, it asks permission to share the image and credits the owner. In many cases, the brand also pays off. One exception seems to be Mr Musk, who is both a successful businessman and a freewheeling personal brand.

“It’s very difficult to talk about something like this without looking like you’re crazy about it,” said Patrick Monahan, 37, a comedian and podcast host whose meme was shared by Mr. Musk without appreciation. “Ultimately, this doesn’t steal a script or an entire song, but it’s the same spiritually. It’s just not cool. “

It may speak more to the simple fact that Mr Musk, who was briefly the richest man in the world according to the Bloomberg Billionaires Index this year, has used Twitter to bolster his personality (and promote cryptocurrencies and stocks, including his own ).

Jamie Trufin, who runs a meme account called @DogeCoinDaddy, said he was disappointed when Mr. Musk posted one of his Doge memes with no credit in March.

“It kills your mood,” said the 24-year-old Trufin. “You work so hard making all of these memes. I could have got a few hundred followers from it, and it would have made the community fatter and happier. He got us all excited about Dogecoin, but he tore down meme pages and did them no credit which kills the fun. “(The price of Dogecoin, a cryptocurrency, has continued to rise, thanks in part to tweets from Mr. Musk.)

In January, Mr. Musk posted a meme about web domains created by Ben Howdle, 31, who has a tech meme account. Mr. Howdle was puzzled as to why someone with such great resources would share someone else’s work with no credit. “You would think if you were the richest person in the world, you wouldn’t have to massage your ego,” he said. (For what it’s worth, Mr. Musk is only the second richest now.)

Mr. Musk has been doing this for a while. In April 2020, he shared a meme created by a comedian with a photo of their dog, which some say Mr. Musk tried to pass it off as his own.

After being criticized in 2019 for sharing artwork on Twitter without credit, Mr. Musk first tweeted, “Always credit everyone.” Then he reversed course: “Nobody should ever be credited,” he wrote, suggesting that “any fool can find out in seconds who the artist was”.

Miles Klee, a 36-year-old Los Angeles writer, heard from a friend that a meme he made in April about vaccinated people enjoying a promiscuous summer had been republished by Mr. Musk. “Someone in my group chat said, ‘LOL, did everyone see Elon steal a meme that Miles made?'”

Mr. Klee is not angry with Mr. Musk, but found the behavior repulsive. “Of course he has his henchmen who are ready to defend what he does,” said Mr. Klee, “but for everyone else who is normal and has been on the Internet for a long time, it’s like:” Yes, that’s a wack Move.'”

Chas Steinbrugge, 19, a freshman who runs the @Trigomemetry meme account, is also the creator of Meme Citations, a website that shares the origins of memes in the Modern Language Association format.

“Personalities like Elon Musk don’t give credit, it hurts the creators,” he said. “He could create a situation where he encourages young meme creators and contributes to the community by tagging whoever created them or adding watermarks.”

Several people whose content was published by Mr. Musk have since asked for payment, be it in dollars, Teslas or Bitcoin. (Mr. Monahan said he was willing to accept “only $ 80,000”.)

Mr. Klee took a newer approach. “Can someone help me create and sell an NFT of a screenshot of Elon Musk posting a horny vaccine meme that I made?” he asked his followers on Twitter. Someone turned the tweet into an NFT that Mr. Klee could sell for $ 1,000 in Ethereum, a cryptocurrency.

Mr Musk, who received a comment on this article via email, responded with two uncredited memes:

Categories
Health

Medicare must OK rule giving seniors entry to FDA-approved medical units

Mina De La O | Digital vision | Getty Images

Dr. Anand Shah is an oncologist and former FDA Assistant Commissioner and former Chief Medical Officer of the Center for Medicare & Medicaid Innovation. He is also an advisor to Morgan Stanley.

Navigating public and commercial health insurance to cover innovative medical products can be a never-ending cycle of bureaucracy.

Medical technologies classified as “safe and effective” by the Food and Drug Administration – the global gold standard for regulating drugs and devices – are not always covered by the Centers for Medicare & Medicaid Services, adding the added hurdle for companies Proof of their requirements must be met Product is “reasonable and necessary”.

Unlike medications, which are typically covered by CMS immediately after FDA approval, seniors can only access many FDA cleared or approved medical diagnoses and devices if they can participate in a CMS approved clinical trial. These studies can take years – additional data and a lengthy regulatory process to determine coverage criteria – and in the meantime sustain potentially life-saving medical interventions from Medicare beneficiaries.

A new policy, due to go into effect in mid-March, would have allowed seniors and their doctors to decide whether or not they needed these devices. However, it was postponed along with other pending regulations when the Biden Administration took office. The proposed Medicare Innovative Technologies Coverage Policy, postponed until May 15 for regulatory review, leverages existing FDA legal expertise under the Breakthrough Devices program to identify a limited number of promising medical technologies, and offers these products a short Medicare warranty. granted on the day of FDA approval.

The proposed policy would be a critical step forward for Medicare beneficiaries to make informed decisions about their care.

Currently, the FDA has approved, authorized, or cleared at least 26 breakthrough diagnoses and devices. These medical products include in vitro diagnostic and imaging platforms for implants and wearable devices that cover a range of diseases, including Ebola, traumatic brain injury, severe emphysema, and heart disease.

As an oncologist who helped develop this medical device policy at CMS, I have looked after many patients who have not had access to state-of-the-art tests such as next-generation DNA sequencing as part of a cancer screening because Medicare does not allow them. The same product can often be obtained by the patient through a commercial insurance policy, which many do not get under the Medicare program after aging. As a last resort, the patient has no choice but to pay out of pocket.

Seniors deserve access to FDA-named breakthrough medical devices – narrowly defined by Congress to include the most promising new technologies, such as those that can treat life-threatening or irreversibly debilitating conditions – once the FDA deems them safe and effective.

It is important that the proposed rule maintain the same high standards required by both the FDA and the CMS. In addition, the existing FDA requirements for post-market surveillance will be maintained. This policy bridges the void for patients who would otherwise not have access to the latest FDA authorized technology while waiting for CMS coverage. Still, it encourages researchers to continue collecting real-world evidence of health outcomes that are specific to Medicare beneficiaries.

Patient protection is maintained as MCIT uses existing procedures to restrict access to new technology when safety or efficacy concerns arise.

There is no disadvantage in approving this policy change. Seniors will have more treatment options, and medical technology innovators can work with CMS to carefully examine these patients over a four-year period, generating meaningful real-world evidence to prove that a new device is “sensible and necessary.” “Is Medicare coverage decision and potentially offers more permanent security.

This policy also encourages early investors to support innovation for the most pressing medical conditions as it creates a clear and predictable path – from investing to developing medical products to regulatory review and subsequent patient access.

If the federal government wants to incentivize investment in developing transformative medical innovations and expand choices for our seniors while promoting rigorous evidence generation, MCIT offers a clear way forward. Too many lives depend on it.

Correction: This editorial has been updated to correct the name of the agency that needs to approve the rule in the headline. It’s CMS.

Categories
Business

To Be Tracked or Not? Apple Is Now Giving Us the Selection.

Given a choice, would any of us want to be followed online to see more relevant digital ads?

We’ll find out in a moment.

On Monday, Apple plans to release iOS 14.5, one of the most anticipated software updates for iPhones and iPads in years. It includes a new privacy tool called App Tracking Transparency that gives us more control over how our data is shared.

Here’s how it works: when an app wants to track our activities in order to share information with third parties such as advertisers, a window will appear on our Apple device asking for our permission. If we say no, the app will have to stop monitoring and sharing our data.

A pop-up window might sound like a little design tweak, but it has caused an uproar in the online advertising industry. Above all, Facebook has gone on the warpath. Last year the social network launched a website and ran full-page ads in newspapers denouncing Apple’s privacy policy as harmful to small businesses.

A big motivator, of course, was that the privacy settings could affect Facebook’s own business. If we don’t let Facebook follow us, it will be more difficult for the company to see what we are shopping for or what we are doing in other apps, making it more difficult for brands to target us with ads (Mark Zuckerberg, CEO of Facebook) Executive, has denied his company’s business is being affected by Apple’s policies.)

“This is a big step in the right direction, if only because it makes Facebook work up a sweat,” said Gennie Gebhart, director of the Electronic Frontier Foundation, a digital rights nonprofit.

But she added, “A big question is, will it work?”

Ms. Gebhart and other privacy professionals said Apple’s new feature may not be enough to end dodgy tracking on iPhones. It could just make developers and ad tech firms find loopholes so they can keep tracking people in different ways, she and others said.

I’ve been testing early versions of iOS 14.5 for about two months to get used to the new privacy controls and other new features. Few developers have tested the pop-up with the public, so my understanding of how well the privacy feature works has been limited.

However, I’ve found that iOS 14.5 has other important new features as well. One of them is the ability to use Siri to work with a music player other than Apple Music like Spotify. That’s a big deal: in the past, you could only ask Siri to play songs through Apple Music, so the voice assistant wasn’t that useful for those who preferred other music services.

Here’s what you need to know about Apple’s new software:

It’s important to understand how tracking works in apps.

For example, let’s say you’re using a shopping app looking for a blender. You look at a Brand X mixer and close the app. Later on, ads for this mixer will be shown on other mobile apps like Facebook and Instagram.

Here’s what happened: The shopping app hired an ad tech company to embed trackers into the app. These trackers checked information on your device to identify you. If you’ve opened other apps that work with the same ad tech company, those apps were able to identify you and serve you ads for Brand X’s mixer.

With Apple’s new data protection feature, you can decide if this should happen. Now when you open some apps, a pop-up window will appear: “Allow [App Name] to track your activity across other companies’ apps and websites? “You can choose between ‘Don’t track the app’ or ‘Allow’.

Let us help you protect your digital life

If we select “Don’t Track App”, two things happen. The first is that Apple is preventing the app from using an Apple device identifier, a random sequence of letters and numbers assigned to our iPhones that is used to track our activity across apps and websites. The second is that we are telling the app developer that, by and large, we do not want our information to be tracked and in any way shared with anyone.

That seems easy. But # 2 is where things get a little complicated too.

Ad tech companies already have many ways to follow us beyond Apple’s device identifier. For example, advertisers can use a method called fingerprinting. This involves looking at seemingly innocuous features of your device – like screen resolution, operating system version and model – and combining them to determine your identity and track you across different apps.

According to data protection researchers, it is difficult for Apple to block all tracking and fingerprints taking place on iPhones. This would require knowing or predicting any new tracking method that an ad tech company is developing.

“From a tech point of view, there’s not much you can do” to stop such tracking, said Mike Audi, founder of Tiki, an app that lets you see what other apps are doing with your data.

However, the change in data protection is still significant, as we are expressly asked for consent. If we tell apps that we don’t want to be tracked and continue to do so, Apple can ban the perpetrators from the App Store.

The pop-up window also makes it easier for people to discover privacy controls, said Stephanie Nguyen, a researcher who has studied user experience design and privacy. In the past, iPhone owners could prevent advertisers from tracking them, but the tools to do that were buried in settings that most people didn’t look at.

“The option was available before, but really, wasn’t it?” Ms. Nguyen said. “It’s a big change – making it visible.”

Starting this week, all apps with tracking behavior must include the App Tracking Transparency pop-up in their next software updates. That means we’ll likely see a small number of apps asking for permission to track us initially, with the number increasing over time as more apps are updated.

Apple’s new software also includes two other interesting new features: the ability to play audio with Siri using a third-party app like Spotify, and the option to quickly unlock an iPhone while wearing a mask.

For many, these will feel long overdue. Siri has generally only worked with Apple Music for music playback since 2015. This is annoying and inconvenient for those who want to use the voice assistant to play songs with other music apps. The change comes because the antitrust investigation decides whether Apple suppresses competition by giving preference to its own apps.

You don’t need to change any settings for Siri to work with other audio services. If you usually listen to music using a third-party app like Spotify, over time Siri will simply find that you prefer that app and act accordingly. (Audio app developers need to program their apps to support Siri. If they haven’t already, this won’t work.) So if you always use Spotify to play music, you can say, “Hey Siri, play the Beatles ”to play a Beatles playlist on Spotify.

The other new feature helps in solving a pandemic problem. For more than a year now, wearing a mask has been especially annoying for owners of newer iPhones with face scanners to unlock the device. That’s because the iPhone camera couldn’t see our covered cups. Apple’s iOS 14.5 finally offers a mechanism to unlock the phone while in a masked state, although it does require wearing an Apple Watch.

Here’s how it works: when you scan your face and the phone finds that it can’t recognize you because your mouth and nose are blocked, it will check that your Apple Watch is unlocked and nearby. The Apple Watch practically acts as proof that you are the one trying to unlock your phone.

For this to work, update the software on your iPhone and Apple Watch and open the Settings app on your iPhone. Scroll down to “Face ID & Passcode”. Go to “Unlock with Apple Watch” in this menu and enable the option to unlock with your Apple Watch if the image scanner detects your face with a mask.

The next time you’re at the grocery store and look at your phone, your watch will vibrate once and unlock your phone. Sweet relief.

Categories
Health

Israel giving 5,000 Covid vaccine doses to Palestinians is insufficient: HRW

Palestinian students wearing face masks stand in line to enter their school after personal training, interrupted as part of the new type of coronavirus (Covid-19) measures, resumed for elementary and secondary school students in the Gaza Strip today on January 13, 2021.

Ali Jadallah | Anadolu Agency | Getty Images

Israel’s decision to give 5,000 doses of the coronavirus vaccine to frontline Palestinian health workers has been criticized by Palestinians and right-wing groups as inadequate and inconsistent with the country’s commitments.

“Israel’s delivery of 5,000 doses of vaccine to Palestinian health workers pales in comparison to the nearly 5 million doses it has already provided to Israeli citizens,” Omar Shakir, Israeli and Palestinian director of Human Rights Watch, told CNBC after the announcement. Just over 5 million people live in the Palestinian Territories.

The office of Israel Defense Minister Benny Gantz announced that the broadcast was approved on Sunday. This was the first such step since the Pfizer BioNTech vaccine began shipping through the 9 million country in mid-December. Israel has since run the world’s fastest vaccination campaign in terms of shots per person, and says more than a quarter of its population has received at least the first dose of vaccine since December 19.

In this aerial photo, taken in Tel Aviv, Israel, on Monday January 4, 2020, people are queuing outside a Covid-19 mass vaccination center in Rabin Sqaure. Israel plans to vaccinate 70% to 80% of its population by April or May. Health Minister Yuli Edelstein has said.

Bloomberg | Bloomberg | Getty Images

The Palestinian Authority did not comment on the news. Until the last announcement, however, no vaccines had reached the Palestinians, except for those who lived in East Jerusalem or worked in the Palestinian hospitals there.

“Israel retains overall control”

For rights organizations and Palestinian interest groups, this was a breach of duty by Israel, which the United Nations has classified as an occupying state over the Palestinian territories.

“Israel retains overall control over land, over the population register, over the movement of people and goods and over the airspace. Under international law, this type of control is linked to obligations towards an occupied population,” said Shakir.

“Israel’s obligations under international law after more than 50 years of occupation, the end of which is not in sight, go far beyond the supply of some vaccines if they have the capacity,” he added, “but rather offer the Palestinians in the occupied territory equal access to the vaccine on par with what it offers its own citizens. “

A health care worker administers a Covid-19 vaccine at Clalit Health Services in the ultra-Orthodox Israeli city of Bnei Brak on January 6, 2021.

JACK GUEZ | AFP | Getty Images

The Israeli health and foreign ministries did not respond to CNBC’s requests for comments in response to these specific statements, but previously stressed that the Israeli coordinator of government activities in the territories had been working with the Palestinian Authority to provide ventilators, test kits and other medical devices to transfer “Donated by the international community.”

There was also joint training of some Israeli-Palestinian medical teams, COGAT told CNBC.

However, Israeli officials argue that ultimate responsibility for health care and vaccine acquisition rests with the Palestinian Authority, which the Palestinians have elected to be the government of the West Bank.

Human Rights Watch’s Shakir denies this. “The fact that Palestinians also bear responsibility does not negate the Israeli role. Ultimately, as occupying powers, they are responsible for the supply and well-being of the occupied population,” he said.

“The hospitals are full of patients”

Nouar Qutob, assistant professor and Covid-19 data researcher at Arab American University in the city of Ramallah on the West Bank, is concerned about the situation.

“Things are worrying. We have cases, cases we don’t know about, the hospitals are already full of patients. And the British variant is now in Palestine,” Qutob told CNBC, referring to a new strain of the first identified coronavirus in the UK and found to be 70% more communicable.

As a resident of East Jerusalem, Qutob has an Israeli residence and was able to receive the Pfizer vaccine. She commutes to work from home in Ramallah, which has a private Covid-19 testing center, but said the rate of people tested has decreased.

“People avoid testing because they don’t want to give up work,” she said.

A worker cleans the classes in preparation for school before teaching in person in specific classes at Taybe Schools in Khan Yunis, Gaza, October 4, 2020 on October 10, 2020.

Mustafa Hassona | Anadolu Agency via Getty Images

The new variant of the virus that now exists in the Palestinian Territories is “really worrying because it means more cases – and we still don’t have the vaccine in the West Bank,” she said. Qutob spoke to CNBC ahead of the Israeli announcement on Sunday, but since the delivery of the 5,000 doses of vaccine is only for frontline Palestinian health workers, it won’t do much to change the infection situation for the general population.

The latest data from the World Health Organization shows 178,900 confirmed coronavirus cases among Palestinians in the West Bank, East Jerusalem and the Gaza Strip, with more than 2,000 deaths.

The Palestinians expect the first major vaccine shipments in March

The Palestinian Authority expects to receive its first shipments of independently sourced vaccines in March.

Yasser Bouzia, an official with the Palestinian Ministry of Health, told CNBC that the PA is currently in a bilateral agreement with AstraZeneca for 2 million doses of its UK-developed vaccine. An additional 2 million vaccine doses are expected to be received through COVAX, a global program established to ensure equitable access to vaccines around the world.

“That will cover almost the majority of the population. And after that we will look to other sources to get nearly 1 million more people vaccinated because we want to vaccinate nearly 5.2 million people,” said Bouzia.

Until then, the infections will still spread despite government restrictions.

“People don’t seem to want to abide by the closings and regulations, they just suffer from bad economic situations,” said Qutob. “I don’t see people following the rules and the virus is spreading, and it’s worrying.”

Categories
Health

Birx says somebody was giving Trump ‘parallel knowledge’ about Covid pandemic

Deborah Birx, Coronavirus Response Coordinator for the White House Coronavirus Task Force, speaks after a White House Coronavirus Task Force briefing at the Department of Health and Human Services in Washington, DC on June 26, 2020.

Joshua Roberts | Getty Images

Dr. Deborah Birx, Trump’s White House coronavirus response coordinator, said in a CBS interview published Sunday that former President Donald Trump was reviewing “parallel” coronavirus pandemic records from someone within the administration.

“I’ve seen the President show off graphics that I’ve never done,” Birx told Margaret Brennan on CBS News’ Face The Nation. “Someone inside created a parallel set of data and graphs that were shown to the President.”

Birx, who announced her resignation as President Joe Biden last week, said she did not know the identity of the person who gave other information to the president. She added that there were Covid-19 deniers within the Trump administration.

“There were people who definitely thought this was a joke,” she said. “I think the information was confusing at first. I think because we weren’t talking about the spectrum of the disease, everyone interpreted what they knew.”

According to the Johns Hopkins University, more than 25 million people have been infected and at least 417,000 people have died in the United States since the pandemic began.

Birx said she had always considered resigning from the White House’s coronavirus task force and was censored by the Trump administration, but denied ever withholding information about the virus.

“When you have a pandemic where you rely on every American to change their behavior, communication is absolutely vital,” she said. “Every time a political leader made a statement that didn’t meet public health needs, our response got derailed. That’s why I took to the streets because I wasn’t censored along the way.”

Birx also said she was increasingly concerned about the Trump administration’s pandemic strategy, particularly right before the presidential election. At the start of the pandemic, Birx had approved of the government’s response, but later frustrated Trump when she emphasized the severity of the pandemic.

“My colleagues, whom I had known for decades – decades – in that one experience because I was in the White House, decided that I had become that political person even though they had known me forever,” said Birx. “I had to ask myself every morning, ‘Is there something I think I can do to respond to this pandemic?’ And that’s what I asked myself every evening. “

Categories
Business

U.S. may ramp up sluggish Covid vaccinations by giving two half doses of Moderna shot

A FDNY EMS Fire Department employee receives a COVID-19 Moderna vaccine amid the coronavirus disease (COVID-19) pandemic in the Manhattan neighborhood of New York City, New York, United States. December 23, 2020.

Carlo Allegri | Reuters

The head of the federal government’s Covid-19 vaccination program said Sunday that health officials are considering the idea of ​​giving a large group of Americans half-volume doses of a vaccine to speed up adoption.

Moncef Slaoui, head of Operation Warp Speed, said on CBS’s “Face the Nation” that one way to speed up immunization against Covid-19 is to give some people two half-volume doses of the Moderna vaccine.

“We know that for the Moderna vaccine, half the dose is given to people between the ages of 18 and 55 – two doses, half the dose, which is exactly the goal of getting twice the number of people using the doses immunize that we have – we know it induces an identical immune response to the 100 microgram dose, “Slaoui said.

“And that’s why we’re in talks with Moderna and the FDA – of course it will ultimately be a decision of the FDA – to accelerate the injection of half the volume,” he added.

Moncef Slaoui, a former executive director of GlaxoSmithKline, speaks to President Donald J. Trump during a vaccine development event in the Rose Garden of the White House on Friday, May 15, 2020 in Washington, DC.

Jabin Botsford | The Washington Post | Getty Images

The comments came in response to why the US is not adopting the strategy of giving all available vaccine doses now, even though the approved vaccines require a second round of firing to be fully effective. The UK has taken this approach in the hope that continued production will enable the second recordings in the future.

Slaoui said it was a mistake to make a decision that was not supported by the experimental data. White House Health Advisor Dr. Anthony Fauci, commented similarly on NBC’s Meet the Press on Sunday, said the strategy “goes against science” and would not solve the problems with the US launch.

“The idea of ​​expanding it so you can get more people is when you don’t have enough vaccine and a lot of people are waiting in line to wait for a vaccine,” Fauci said. “That’s not our problem now. We have a vaccine. We have to get it into people’s arms. It really is the right solution to the wrong problem.”

The FDA and Moderna did not immediately respond to requests for comment.

The dispute over different vaccination approaches stems from the fact that the introduction of the vaccine in the US did not achieve the goals of Operation Warp Speed ​​and the pandemic continues to devastate the country. President Donald Trump has blamed states for the slow adoption as the number of vaccinations given lags behind the number of vaccines sent and delivered.

Health officials wanted to inject a vaccine to 20 million Americans by the end of the year. However, according to the Centers for Disease Control and Prevention, only about 4.2 million people had received gunfire by January 2.

The last 7-day average for new cases of the coronavirus in the US is 205,093, according to John Hopkins University. That number has grown by 8% week-to-week, although tests and reports tended to be inconsistent during the holiday season. According to Johns Hopkins, the nation has an average of more than 2,600 deaths a day attributed to the virus.

Categories
Business

MacKenzie Scott Proclaims $4.2 Billion Extra in Charitable Giving

In her brief career as one of the world’s foremost philanthropists, MacKenzie Scott has made a name for herself for the sheer volume and speed of her donations, donating nearly $ 6 billion in her fortune this year alone.

Ms. Scott, a writer who was once married to Amazon founder and CEO Jeff Bezos, announced in a Medium post Tuesday that she’d given nearly $ 4.2 billion to 384 organizations over the past four months have. Many of the groups are focused on basic needs for millions of people during a difficult year, including food banks and meals on wheels.

“This pandemic has been a wrecking ball in the lives of Americans who have already struggled,” Ms. Scott wrote. “Economic losses and health consequences were worse for women, people of color and people living in poverty alike. Meanwhile, it has significantly increased the wealth of the billionaires. “

Mainstays like NAACP, Easterseals, Goodwill and United Way were on the list. This also applies to more than 100 separate YMCA and YWCA organizations across the country which, like many nonprofits, have lost tremendous revenue even though the demand for their services has increased.

And smaller organizations like a nonprofit affordable home lender in Minnesota and a group helping people pay off medical debts also received funding.

Ms. Scott’s post did not include the amounts paid to each organization, but it did say that the full amount pledged is prepaid and unrestricted or “no commitment” as she put it.

Morgan State University, a historically black university in Baltimore, announced it had received $ 40 million, the largest private gift in the institution’s history. Ms. Scott said the money went to groups in all 50 states, Washington and Puerto Rico.

Chuck Collins, director of the Charity Reform Initiative at the Institute for Policy Studies, said he couldn’t think of anyone who gave away more this year, at least in terms of publicly announced grants. “She’s responding to the current moment with urgency,” said Mr. Collins.

“They think of all of these tech achievements, they are the big disruptors, but it disrupts the norms surrounding billionaire philanthropy by moving fast and not creating a private foundation for their great-grandchildren to give away the money,” added Collins.

The Institute for Political Studies has pushed for legislation that will double the amount of money foundations will have to pay from 5 percent a year to 10 percent for the next three years to meet the yawning needs caused by the pandemic.

For context, the Gates Foundation, in many ways the largest and most influential nonprofit in the world, raised $ 5.1 billion in direct grants with the fortunes of both Microsoft founder Bill Gates and investor Warren E. Buffett. Dollars awarded in 2019. However, the Gates Foundation has decades of experience and more than 1,600 employees, while Ms. Scott only referred to a team of advisors to help her find good causes.

While the Gates Foundation may donate more than $ 5.9 billion through its Covid-19 response, the number shows how quickly Ms. Scott has risen to become the number one donor worldwide.

In July, Ms. Scott announced that she had donated $ 1.7 billion to historically black colleges and universities, as well as groups promoting women’s rights, LGBTQ equality and the fight against climate change, among others. Howard University said at the time it had received $ 40 million, a donation it described as “transformative”.

When Ms. Scott and Mr. Bezos were divorced last year, Ms. Scott received 4 percent of Amazon’s outstanding shares, or 19.7 million shares. They were valued at around $ 38.3 billion at the time. Those stocks would be valued at approximately $ 62 billion today after a pandemic-triggered surge in Amazon stocks. It’s not clear how many stocks she sold.